Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1779, Issue 10, 2008, Pages 590-598

  Olsson, André ^a   Olsson, Inge ^a   Dhanda, Rakesh Singh ^a  

^a C14 BMC ^*  (Sweden)

Author keywords

AML1 ETO; ETO; hSIN3B; Leukaemia; MTG16

Indexed keywords

BINDING PROTEIN; COREPRESSOR SIN3B; LUCIFERASE; MYELOID TRANSFORMING GENE RELATED PROTEIN1; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN DERIVATIVE; THYMIDINE KINASE; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL LINE; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; MYELOID TRANSLOCATION GENE ON CHROMOSOME 16; OLIGOMERIZATION; PRIORITY JOURNAL; REPORTER GENE;

CELLS, CULTURED; DIMERIZATION; DOWN-REGULATION; HISTONE DEACETYLASES; HUMANS; MULTIGENE FAMILY; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEINS;

EID: 52249083489     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2008.06.001     Document Type: Article

References (33)

1. Gelmetti V., Zhang J., Fanelli M., Minucci S., Pelicci P.G., and Lazar M.A. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18 (1998) 7185-7191
2. Lutterbach B., Westendorf J.J., Linggi B., Patten A., Moniwa M., Davie J.R., Huynh K.D., Bardwell V.J., Lavinsky R.M., Rosenfeld M.G., Glass C., Seto E., and Hiebert S.W. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18 (1998) 7176-7184
3. Wang J., Hoshino T., Redner R.L., Kajigaya S., and Liu J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A 95 (1998) 10860-10865
4. Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., Downing J.R., Meyers S., and Hiebert S.W. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21 (2001) 6470-6483
5. Hildebrand D., Tiefenbach J., Heinzel T., Grez M., and Maurer A.B. Multiple regions of ETO cooperate in transcriptional repression. J. Biol. Chem. 276 (2001) 9889-9895
6. Zhang J., Hug B.A., Huang E.Y., Chen C.W., Gelmetti V., Maccarana M., Minucci S., Pelicci P.G., and Lazar M.A. Oligomerization of ETO is obligatory for corepressor interaction. Mol. Cell. Biol. 21 (2001) 156-163
7. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., Yang W.M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K., and Rosenfeld M.G. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387 (1997) 43-48
8. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., and Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell. 89 (1997) 349-356
9. Feinstein P.G., Kornfeld K., Hogness D.S., and Mann R.S. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics 140 (1995) 573-586
10. Kitabayashi I., Ida K., Morohoshi F., Yokoyama A., Mitsuhashi N., Shimizu K., Nomura N., Hayashi Y., and Ohki M. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell. Biol. 18 (1998) 846-858
11. Erickson P.F., Robinson M., Owens G., and Drabkin H.A. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res 54 (1994) 1782-1786
12. Davis J.N., Williams B.J., Herron J.T., Galiano F.J., and Meyers S. ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene. 18 (1999) 1375-1383
13. Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M., Sugiyama D., Lary J., Cole J., Dauter Z., Minor W., Speck N.A., and Bushweller J.H. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell. 9 (2006) 249-260
14. Lutterbach B., Sun D., Schuetz J., and Hiebert S.W. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol. 18 (1998) 3604-3611
15. Goardon N., Lambert J.A., Rodriguez P., Nissaire P., Herblot S., Thibault P., Dumenil D., Strouboulis J., Romeo P.H., and Hoang T. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. Embo. J. 25 (2006) 357-366
16. Lindberg S.R., Olsson A., Persson A.M., and Olsson I. Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. Eur. J. Haematol. 71 (2003) 439-447
17. McGhee L., Bryan J., Elliott L., Grimes H.L., Kazanjian A., Davis J.N., and Meyers S. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem 89 (2003) 1005-1018
18. Schuh A.H., Tipping A.J., Clark A.J., Hamlett I., Guyot B., Iborra F.J., Rodriguez P., Strouboulis J., Enver T., Vyas P., and Porcher C. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol. 25 (2005) 10235-10250
19. Lindberg S.R., Olsson A., Persson A.M., and Olsson I. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation. Exp. Hematol 33 (2005) 189-198
20. Amann J.M., Chyla B.J., Ellis T.C., Martinez A., Moore A.C., Franklin J.L., McGhee L., Meyers S., Ohm J.E., Luce K.S., Ouelette A.J., Washington M.K., Thompson M.A., King D., Gautam S., Coffey R.J., Whitehead R.H., and Hiebert S.W. Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Mol. Cell. Biol. 25 (2005) 9576-9585
21. Calabi F., Pannell R., and Pavloska G. Gene targeting reveals a crucial role for MTG8 in the gut. Mol. Cell. Biol. 21 (2001) 5658-5666
22. Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J., and Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80 (1992) 1825-1831
23. Miyoshi H., Kozu T., Shimizu K., Enomoto K., Maseki N., Kaneko Y., Kamada N., and Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. Embo J. 12 (1993) 2715-2721
24. Gamou T., Kitamura E., Hosoda F., Shimizu K., Shinohara K., Hayashi Y., Nagase T., Yokoyama Y., and Ohki M. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91 (1998) 4028-4037
25. Minucci S., Maccarana M., Cioce M., De Luca P., Gelmetti V., Segalla S., Di Croce L., Giavara S., Matteucci C., Gobbi A., Bianchini A., Colombo E., Schiavoni I., Badaracco G., Hu X., Lazar M.A., Landsberger N., Nervi C., and Pelicci P.G. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol. Cell. 5 (2000) 811-820
26. So C.W., and Cleary M.L. Dimerization: a versatile switch for oncogenesis. Blood 104 (2004) 919-922
27. Lausen J., Liu S., Fliegauf M., Lubbert M., and Werner M.H. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25 (2006) 1349-1357
28. Dhanda R.S., Rondin S.L., and Olsson I. The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Molecular Biology 9 (2008) 8
29. Hoogeveen A.T., Rossetti S., Stoyanova V., Schonkeren J., Fenaroli A., Schiaffonati L., van Unen L., and Sacchi N. The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies. Oncogene 21 (2002) 6703-6712
30. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
31. Lausen J., Cho S., Liu S., and Werner M.H. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. J. Biol. Chem. 279 (2004) 49281-49288
32. Liu S., Shen T., Huynh L., Klisovic M.I., Rush L.J., Ford J.L., Yu J., Becknell B., Li Y., Liu C., Vukosavljevic T., Whitman S.P., Chang K.S., Byrd J.C., Perrotti D., Plass C., and Marcucci G. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res. 65 (2005) 1277-1284
33. Hug B.A., Lee S.Y., Kinsler E.L., Zhang J., and Lazar M.A. Cooperative function of Aml1-ETO corepressor recruitment domains in the expansion of primary bone marrow cells. Cancer Res. 62 (2002) 2906-2912